EPINTEK 熠品 is a Health Care startup based in China, founded in 2020. It operates as a Medical Device CRO and Testing Center with a focus on the rapidly developing medical device and biomedical industries. The company offers integrated services including preclinical study, inspection, and testing, regulatory affairs & registration, and clinical trial CRO services to domestic and foreign manufacturing companies and research institutes. The EPIN Operation Center is situated in the Hongqiao Central Business District, Shanghai, while its biomedical laboratory is located in Wujiang District, Suzhou. Additionally, the electrical medical & wireless communication (EMC) laboratory is based in Suzhou Industrial Park, and the consumables testing center, operating rooms, large animal center, and the South China Biomedical R&D and Testing Center are in Baiyun District, Guiyang. Moreover, the R&D and Testing Center for Orthopedic, Implantable, and Interventional Devices is located in Hefei High-tech Zone. The company recently secured a Series C investment on 28 August 2023, with the backing of October Capital. EPINTEK's integrated services and extensive facilities position it as a key player in the medical device technical service platform space. With its government investment and strategic locations, EPINTEK is poised for substantial growth and potential global impact.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series C | Unknown | 1 | 28 Aug 2023 | |
Series C | CNY99.00M | 3 | Guiyang Venture Capital, Furong Capital | 01 Jan 2022 |
Series C | Unknown | 3 | Guiyang Venture Capital | 08 Oct 2021 |
Series B | Unknown | 3 | Guiyang Venture Capital, Batten Capital | 01 Mar 2021 |
Series B | Unknown | 1 | Batten Capital | 01 Nov 2020 |
No recent news or press coverage available for EPINTEK 熠品.